Yong Kee Kim - Search Results

Year	Number of Results
2001	1
2002	4
2003	3
2004	2
2005	4
2006	5
2007	6
2008	6
2009	5
2010	4
2011	4
2012	5
2013	4
2014	4
2015	7
2016	7
2017	7
2018	2
2019	6
2020	6
2021	2
2022	4
2023	2
2024	0

1

Protein arginine methyltransferases: promising targets for cancer therapy.

Hwang JW, Cho Y, Bae GU, Kim SN, Kim YK. Hwang JW, et al. Among authors: kim yk. Exp Mol Med. 2021 May;53(5):788-808. doi: 10.1038/s12276-021-00613-y. Epub 2021 May 18. Exp Mol Med. 2021. PMID: 34006904 Free PMC article. Review.

2

Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance.

Cho Y, Kim YK. Cho Y, et al. Among authors: kim yk. Front Oncol. 2020 Jun 2;10:764. doi: 10.3389/fonc.2020.00764. eCollection 2020. Front Oncol. 2020. PMID: 32582535 Free PMC article. Review.

3

Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells.

Lee H, Ha S, Choi S, Do S, Yoon S, Kim YK, Kim WY. Lee H, et al. Among authors: kim yk. Int J Mol Sci. 2023 May 31;24(11):9530. doi: 10.3390/ijms24119530. Int J Mol Sci. 2023. PMID: 37298484 Free PMC article.

4

PRMT7 Inhibitor SGC8158 Enhances Doxorubicin-Induced DNA Damage and Its Cytotoxicity.

Jeong A, Cho Y, Cho M, Bae GU, Song DG, Kim SN, Kim YK. Jeong A, et al. Among authors: kim yk. Int J Mol Sci. 2022 Oct 14;23(20):12323. doi: 10.3390/ijms232012323. Int J Mol Sci. 2022. PMID: 36293180 Free PMC article.

5

PRMT7 ablation in cardiomyocytes causes cardiac hypertrophy and fibrosis through β-catenin dysregulation.

Ahn BY, Jeong MH, Pyun JH, Jeong HJ, Vuong TA, Bae JH, An S, Kim SW, Kim YK, Ryu D, Kim HJ, Cho H, Bae GU, Kang JS. Ahn BY, et al. Among authors: kim yk. Cell Mol Life Sci. 2022 Jan 28;79(2):99. doi: 10.1007/s00018-021-04097-x. Cell Mol Life Sci. 2022. PMID: 35089423

6

5,7-Dihydroxy-6-geranylflavanone improves insulin sensitivity through PPARα/γ dual activation.

Lee W, Yoon G, Kim MC, Kwon HC, Bae GU, Kim YK, Kim SN. Lee W, et al. Among authors: kim yk. Int J Mol Med. 2016 May;37(5):1397-404. doi: 10.3892/ijmm.2016.2531. Epub 2016 Mar 17. Int J Mol Med. 2016. PMID: 26986637

7

SPC-180002, a SIRT1/3 dual inhibitor, impairs mitochondrial function and redox homeostasis and represents an antitumor activity.

Cho Y, Hwang JW, Park NJ, Moon J, Ali KH, Seo YH, Kim IS, Kim SN, Kim YK. Cho Y, et al. Among authors: kim yk. Free Radic Biol Med. 2023 Nov 1;208:73-87. doi: 10.1016/j.freeradbiomed.2023.07.033. Epub 2023 Aug 2. Free Radic Biol Med. 2023. PMID: 37536458

8

PRMT6-mediated H3R2me2a guides Aurora B to chromosome arms for proper chromosome segregation.

Kim S, Kim NH, Park JE, Hwang JW, Myung N, Hwang KT, Kim YA, Jang CY, Kim YK. Kim S, et al. Among authors: kim yk. Nat Commun. 2020 Jan 30;11(1):612. doi: 10.1038/s41467-020-14511-w. Nat Commun. 2020. PMID: 32001712 Free PMC article.

9

Dehydrocorydaline promotes myogenic differentiation via p38 MAPK activation.

Yoo M, Lee SJ, Kim YK, Seo DW, Baek NI, Ryu JH, Kang JS, Bae GU. Yoo M, et al. Among authors: kim yk. Mol Med Rep. 2016 Oct;14(4):3029-36. doi: 10.3892/mmr.2016.5653. Epub 2016 Aug 19. Mol Med Rep. 2016. PMID: 27573543 Free PMC article.

10

TIMP-2 disrupts FGF-2-induced downstream signaling pathways.

Seo DW, Kim SH, Eom SH, Yoon HJ, Cho YR, Kim PH, Kim YK, Han JW, Diaz T, Wei BY, Stetler-Stevenson WG. Seo DW, et al. Among authors: kim yk. Microvasc Res. 2008 Nov;76(3):145-51. doi: 10.1016/j.mvr.2008.07.003. Epub 2008 Jul 29. Microvasc Res. 2008. PMID: 18721821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year